DCSIMG
SWTS.news.image.e

Funding for kidney cancer drug withheld

KIDNEY cancer sufferers in the Lothians have received a blow after funding for a new drug was refused.

The Scottish Medicines Consortium (SMC) has been criticised for ruling against the second-line treatment by charities across the country.

Because treatment options for the disease are limited, campaigners saw the role of the Afinitor drug as key to patient survival.

And while the SMC agreed it was clinically effective for those who had not responded to first-line treatment, it was ruled it would be too expensive to gain acceptance by the council.

Pat Hanlon, Trustee of Kidney Cancer UK said: "The SMC decision is devastating news for people living with advanced kidney cancer in Scotland who will be refused access to an effective treatment."


Find It

"Business owner? - Claim your business and Advertise with us"

In association with qype logo

Looking for...

Featured advertisers

Jobs

Search for a job

Motors

Search for a car

Property

Search for a house

Weather for Edinburgh

Wednesday 15 February 2012

5 day forecast

Today

Cloudy

Cloudy

Temperature: 6 C to 11 C

Wind Speed: 18 mph

Wind direction: West

Tomorrow

Cloudy

Cloudy

Temperature: 6 C to 11 C

Wind Speed: 20 mph

Wind direction: South west

Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.